Deal Snapshot
StageBio Acquires TPL Path Labs to Extend Global Presence in Pathology Solutions
Friday 23 October 2020

US-based StageBio, a provider of GLP-compliant necropsy, histology, pathology and specimen archiving services for both preclinical and clinical research, has acquired Germany based CRO service provider TPL Path Labs to expand StageBio's preclinical and clinical laboratory resources, the company said.

The combined organisation offers an expanded array of histopathology, molecular pathology, toxicology, digital image analysis and related solutions to biopharma, medical device and academic researchers across the US, Europe and beyond. StageBio is a portfolio company of Ampersand Capital Partners.

Date Published: 23/10/2020